EcoDrugPlus

Ensembl ID : ENSHCOG00000003682
Gene Symbol: -
Cross references: -
127 Possible Orthologues:

Ensembl ID : ENSHCOG00000009335
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSHCOG00000000427
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSHCOG00000006766
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSHCOG00000004335
Gene Symbol: -
Cross references: -
143 Possible Orthologues:

Ensembl ID : ENSHCOG00000006323
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSHCOG00000008504
Gene Symbol: -
Cross references: -
403 Possible Orthologues:

Ensembl ID : ENSHCOG00000020870
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSHCOG00000010763
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSHCOG00000013320
Gene Symbol: -
Cross references: -
235 Possible Orthologues:

Ensembl ID : ENSHCOG00000021178
Gene Symbol: -
Cross references: -
176 Possible Orthologues:

Ensembl ID : ENSHCOG00000018601
Gene Symbol: -
Cross references: -
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).